Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension, Grade 1”

294 trials

Showing 20 of 294 results

Large-scale testing (Phase 3)Study completedNCT00133185
What this trial is testing

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 31
Testing effectiveness (Phase 2)Study completedNCT01974570
What this trial is testing

Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects

Who this might be right for
Prehypertension
KGK Science Inc. 144
Large-scale testing (Phase 3)Study completedNCT00263003
What this trial is testing

Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension

Who this might be right for
Hypertension
Sanofi 40
Early research (Phase 1)Study completedNCT01331486
What this trial is testing

Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract

Who this might be right for
PrehypertensionMild Hypertension
University of North Carolina, Chapel Hill 24
Not applicableLooking for participantsNCT06057051
What this trial is testing

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Who this might be right for
Glaucoma
Glaukos Corporation 245
Large-scale testing (Phase 3)Study completedNCT02206659
What this trial is testing

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 20
Post-approval studies (Phase 4)Looking for participantsNCT07247058
What this trial is testing

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Who this might be right for
Mild Autonomous Cortisol Secretion (MACS)
Johns Hopkins University 10
Large-scale testing (Phase 3)UnknownNCT01956786
What this trial is testing

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Who this might be right for
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd 540
Not applicableUnknownNCT01906567
What this trial is testing

İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels?

Who this might be right for
Mild Pre-eclampsiaSevere Preeclampsia
Zekai Tahir Burak Women's Health Research and Education Hospital 90
Large-scale testing (Phase 3)Study completedNCT01001572
What this trial is testing

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Novartis 932
Post-approval studies (Phase 4)Study completedNCT00328965
What this trial is testing

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Who this might be right for
Diabetes Mellitus, Type 2Essential Hypertension
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00200460
What this trial is testing

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

Who this might be right for
Hypertension
Mylan Bertek Pharmaceuticals 825
Post-approval studies (Phase 4)Study completedNCT00698646
What this trial is testing

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Who this might be right for
Hypertension
Novartis Pharmaceuticals 384
Large-scale testing (Phase 3)Study completedNCT02177487
What this trial is testing

Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 100
Large-scale testing (Phase 3)WithdrawnNCT02969265
What this trial is testing

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Who this might be right for
Hypertension
Takeda
Early research (Phase 1)Study completedNCT05291546
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9035 in Healthy Adult Volunteers and Mildly Hypertensive Participants

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 93
Large-scale testing (Phase 3)Study completedNCT00250562
What this trial is testing

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Who this might be right for
Hypertension
Novartis 1,171
Not applicableUnknownNCT04498299
What this trial is testing

Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness

Who this might be right for
Echocardiography, StressCOVID-19Hypertension, Pulmonary
Miguel Ayala León 30
Post-approval studies (Phase 4)Study completedNCT00130156
What this trial is testing

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

Who this might be right for
High Blood Pressure
Eisai Inc. 93
Post-approval studies (Phase 4)Study completedNCT00335673
What this trial is testing

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

Who this might be right for
Hypertension
Sanofi 1,630
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation